322 related articles for article (PubMed ID: 25741887)
1. Effect of HIV Infection and Highly Active Antiretroviral Therapy on Hearing Function: A Prospective Case-Control Study From Cameroon.
Fokouo JV; Vokwely JE; Noubiap JJ; Nouthe BE; Zafack J; Minka Ngom ES; Dalil AB; Ngo Nyeki AR; Bengono G; Njock R
JAMA Otolaryngol Head Neck Surg; 2015 May; 141(5):436-41. PubMed ID: 25741887
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of hearing-loss among HAART-treated children in the Horn of Africa.
Smith AF; Ianacone DC; Ensink RJH; Melaku A; Casselbrant ML; Isaacson G
Int J Pediatr Otorhinolaryngol; 2017 Jul; 98():166-170. PubMed ID: 28583495
[TBL] [Abstract][Full Text] [Related]
3. Audiologic and vestibular findings in a sample of human immunodeficiency virus type-1-infected Mexican children under highly active antiretroviral therapy.
Palacios GC; Montalvo MS; Fraire MI; Leon E; Alvarez MT; Solorzano F
Int J Pediatr Otorhinolaryngol; 2008 Nov; 72(11):1671-81. PubMed ID: 18814921
[TBL] [Abstract][Full Text] [Related]
4. Hearing Loss in HIV-Infected Children in Lilongwe, Malawi.
Hrapcak S; Kuper H; Bartlett P; Devendra A; Makawa A; Kim M; Kazembe P; Ahmed S
PLoS One; 2016; 11(8):e0161421. PubMed ID: 27551970
[TBL] [Abstract][Full Text] [Related]
5. Highly active antiretroviral therapy and dyslipidemia in people living with HIV/AIDS in Fako Division, South West Region of Cameroon.
Nsagha DS; Weledji EP; Assob NJ; Njunda LA; Tanue EA; Kibu OD; Ayima CW; Ngowe MN
BMC Cardiovasc Disord; 2015 Aug; 15():95. PubMed ID: 26315756
[TBL] [Abstract][Full Text] [Related]
6. Association Between Childhood Hearing Disorders and Tinnitus in Adulthood.
Aarhus L; Engdahl B; Tambs K; Kvestad E; Hoffman HJ
JAMA Otolaryngol Head Neck Surg; 2015 Nov; 141(11):983-9. PubMed ID: 26540147
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of Hypertension in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) Compared with HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
PLoS One; 2016; 11(2):e0148100. PubMed ID: 26862763
[TBL] [Abstract][Full Text] [Related]
8. Otologic and audiological evaluation among HIV patients in Ilorin, Nigeria.
Alabi BS; Salami AK; Afolabi OA; Aremu SK; Olawumi HO; Odeigah LO; Akande HJ
Nig Q J Hosp Med; 2013; 23(1):29-32. PubMed ID: 24579491
[TBL] [Abstract][Full Text] [Related]
9. Prevalence of hearing loss among newly diagnosed highly active antiretroviral therapy (Haart) naive adult patients in port harcourt.
Ude AE; da Lilly-Tariah OB; Onotai LO; Chinenye S
Niger J Clin Pract; 2022 Dec; 25(12):1992-1997. PubMed ID: 36537456
[TBL] [Abstract][Full Text] [Related]
10. Oral lesions as clinical markers of highly active antiretroviral therapy failure: a nested case-control study in Mexico City.
Ramírez-Amador V; Ponce-de-León S; Anaya-Saavedra G; Crabtree Ramírez B; Sierra-Madero J
Clin Infect Dis; 2007 Oct; 45(7):925-32. PubMed ID: 17806063
[TBL] [Abstract][Full Text] [Related]
11. A Comparison of the Diabetes Risk Score in HIV/AIDS Patients on Highly Active Antiretroviral Therapy (HAART) and HAART-Naïve Patients at the Limbe Regional Hospital, Cameroon.
Dimala CA; Atashili J; Mbuagbaw JC; Wilfred A; Monekosso GL
PLoS One; 2016; 11(5):e0155560. PubMed ID: 27195956
[TBL] [Abstract][Full Text] [Related]
12. Initiating highly active antiretroviral therapy and continuity of HIV care: the impact of incarceration and prison release on adherence and HIV treatment outcomes.
Palepu A; Tyndall MW; Chan K; Wood E; Montaner JS; Hogg RS
Antivir Ther; 2004 Oct; 9(5):713-9. PubMed ID: 15535408
[TBL] [Abstract][Full Text] [Related]
13. Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.
Van Vaerenbergh K
Verh K Acad Geneeskd Belg; 2001; 63(5):447-73. PubMed ID: 11813503
[TBL] [Abstract][Full Text] [Related]
14. Is there any relationship between hearing threshold levels and CD4 cell count of human immunodeficiency virus infected adults?
Fasunla AJ; Ijitola JO; Akpa OM; Nwaorgu OGB; Taiwo B; Olaleye DO; Murphy RL; Adewole IF; Akinyinka OO
Afr J Med Med Sci; 2016 May; 45(1):51-60. PubMed ID: 28686827
[TBL] [Abstract][Full Text] [Related]
15. Hearing function in patients living with HIV/AIDS.
Luque AE; Orlando MS; Leong UC; Allen PD; Guido JJ; Yang H; Wu H
Ear Hear; 2014; 35(6):e282-90. PubMed ID: 25127320
[TBL] [Abstract][Full Text] [Related]
16. A prospective study of highly active antiretroviral therapy in Indian human immunodeficiency virus positive patients.
Rajesh R; Vidyasagar S; Varma DM; Naik A; Hegde BM; Guddattu V; Kamath A
Int J Risk Saf Med; 2013 Jan; 25(1):53-65. PubMed ID: 23442298
[TBL] [Abstract][Full Text] [Related]
17. Prevalence of hearing loss and tinnitus in a group of adults with Human Immunodeficiency Virus.
Millar A; Joubert K; Naude A
S Afr J Commun Disord; 2020 Feb; 67(1):e1-e7. PubMed ID: 32129664
[TBL] [Abstract][Full Text] [Related]
18. [Lipodystrophy and echographic hepatic steatosis in HIV-positive patients under highly active antiretroviral therapy (HAART) in Yaounde (Cameroon)].
Ongolo-Zogo P; Nkodo Mbia N; Mvogo Minkala TL; Biwole Sida M; Kouanfack C; Nko Amvene S
Bull Soc Pathol Exot; 2012 Dec; 105(5):353-60. PubMed ID: 22886433
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for active tuberculosis after antiretroviral treatment initiation in Abidjan.
Seyler C; Toure S; Messou E; Bonard D; Gabillard D; Anglaret X
Am J Respir Crit Care Med; 2005 Jul; 172(1):123-7. PubMed ID: 15805184
[TBL] [Abstract][Full Text] [Related]
20. CD4+ cell count, viral load, and highly active antiretroviral therapy use are independent predictors of body composition alterations in HIV-infected adults: a longitudinal study.
McDermott AY; Terrin N; Wanke C; Skinner S; Tchetgen E; Shevitz AH
Clin Infect Dis; 2005 Dec; 41(11):1662-70. PubMed ID: 16267741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
